Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Qilu Pharmaceutical pays $38M upfront for greater China rights to Minghui's ADC
Fierce Biotech
Friday, May 9, 2025 - 9:32am
tags:
Qilu Pharmaceutical, China, Minguhui Pharmaceutical
Moderna’s flu-COVID vaccine beats standard shots
Beckers Hospital Review
Friday, May 9, 2025 - 9:30am
tags:
Moderna Therapeutics, MRNA, vaccines, flu-COVID combo vaccines, COVID-19, clinical trials
Leo tames eczema in phase 2b, reporting primary endpoint hit for ex-argenx asset
Fierce Biotech
Friday, May 9, 2025 - 9:26am
tags:
LEO Pharma, eczema, temtokibart, clinical trials
Johnson & Johnson (JNJ) reports Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis
Marketscreener
Friday, May 9, 2025 - 8:59am
tags:
JNJ, clinical trials, icotrokinra, psoriasis
US, UK reach deal on tariffs, market access
Medtech Dive
Friday, May 9, 2025 - 8:37am
tags:
tariffs, Donald Trump, UK
AZ plots wider Imfinzi use in bladder cancer after trial win
Pharmaphorum
Friday, May 9, 2025 - 8:30am
tags:
AstraZeneca, Imfinzi, bladder cancer, clinical trials
Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures
Fierce Biotech
Friday, May 9, 2025 - 8:28am
tags:
Sanofi, IGM Biosciences, layoffs
In first oncology expert meeting under Makary, FDA spotlights cancer drugs from J&J, Pfizer, Roche and UroGen
Fierce Pharma
Thursday, May 8, 2025 - 10:56pm
tags:
FDA, Richard Pazdur, Marty Makary, cancer, oncology, JNJ, Pfizer, Roche, Urogen
Accelerated FDA Approval Makes Verastem Drug the First Therapy for Rare Type of Ovarian Cancer
MedCity News
Thursday, May 8, 2025 - 10:54pm
tags:
Verastem Oncology, ovarian cancer, KRAS mutation, FDA
Illumina outlines $4.18B to $4.26B guidance for 2025 amid China headwinds and strategic cost reductions
MSN/Seeking Alpha
Thursday, May 8, 2025 - 10:51pm
tags:
Illumina, Medtech, earnings, China
Sanofi exec tells biotechs not to scrimp on clinical trial design
Clinical Trials Arena
Thursday, May 8, 2025 - 10:47pm
tags:
Sanofi, biotech, clinical trials, clinical trial design
$1.8 billion in NIH grant cuts hit minority health research the hardest
Science News
Thursday, May 8, 2025 - 10:45pm
tags:
NIH, federal grant, R&D, Donald Trump
Viatris’ new form of old pain drug scores in large trials
BioPharma Dive
Thursday, May 8, 2025 - 10:42pm
tags:
Viatris, post surgical pain, meloxicam, clinical trials
J&J survey finds pace of oncology innovation is overwhelming physicians
Fierce Pharma
Thursday, May 8, 2025 - 11:17am
tags:
JNJ, oncology, oncologists, physicians, innovation
Novavax sales jump 600% YoY as COVID-19 vaccine still in limbo at FDA
BioSpace
Thursday, May 8, 2025 - 11:14am
tags:
Novavax, earnings, vaccines, COVID-19
Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.
BioPharma Dive
Thursday, May 8, 2025 - 11:11am
tags:
FDA, CBER, Vinay Prasad
Gilead reports final outcomes from trial of bulevirtide for chronic HDV
Clinical Trials Arena
Thursday, May 8, 2025 - 11:06am
tags:
Gilead Sciences, clinical trials, hepatitis D, buleviritide
GSK posts phase 3 itch data as it closes in on FDA approval
Fierce Biotech
Thursday, May 8, 2025 - 11:04am
tags:
GSK, clinical trials, liver disease, linerixibat
FDA ends advance notice for foreign drugmaker inspections
Beckers Hospital Review
Thursday, May 8, 2025 - 11:02am
tags:
FDA, regulatory, foreign drug inspections, drug manufacturing
AbbVie’s Skyrizi leads pharma TV ad rankings for April
Medical Marketing and Media
Thursday, May 8, 2025 - 10:59am
tags:
AbbVie, Skyrizi, DTC advertising, television ads

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.